Rekod bukti kaedah

Phase I Clinical Trial

A Phase I clinical trial is the first stage of human testing for a new drug, biologic, or intervention. Its primary objective is to evaluate safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) rather than therapeutic efficacy. Small cohorts of participants — typically healthy volunteers or patients with advanced disease — receive sequentially increasing doses to identify the maximum tolerated dose (MTD) and the dose-limiting toxicities (DLTs) that define the boundary for subsequent trials.

Sources recorded, not reviewed

Rekod sumber

Petikan disalin secara verbatim daripada rekod sumber kaedah. Tiada pengesahan peringkat tuntutan disimpulkan daripadanya.

Phase I Clinical Trial (First-in-Human / Dose-Escalation Study)

Rekod kaedah taksonomik · process-pipeline / epidemiology

Buka kaedah penuh

Tuntutan yang dikurasi

Tuntutan disimpan dalam lejar bukti, setiap satu dengan penilaiannya sendiri.

Tiada tuntutan terkurasi lagi

Pandangan ini tidak mencipta penilaian tuntutan apabila lejar tiada.

Kaedah berkaitan

Dijana daripada graf kaedah dan ditunjukkan sebagai perhubungan yang dicadangkan mesin — tiada tuntutan bukti disimpulkan.

Taxonomic bucketAdaptive Randomized Clinical Trialmachine-suggested · Relational suggestion, not evidence.Same method familyDiagnostic Accuracy Study Designmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketDose-Response Analysismachine-suggested · Relational suggestion, not evidence.Taxonomic bucketPhase II clinical trialmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketPhase III clinical trialmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketRandomized clinical trialmachine-suggested · Relational suggestion, not evidence.